CoChat

Current Status and Emerging Trends in Colorectal Cancer Screening and Diagnostics

Open access

The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.

Abstract

Colorectal cancer (CRC) is a prevalent and potentially fatal disease categorized based on its high incidences and mortality rates, which raised the need for effective diagnostic strategies for the early detection and management of CRC. While there are several conventional cancer diagnostics available, they have certain limitations that hinder their effectiveness. Significant research efforts are currently being dedicated to elucidating novel methodologies that aim at comprehending the intricate molecular mechanism that underlies CRC. Recently, microfluidic diagnostics have emerged as a pivotal solution, offering non-invasive approaches to real-time monitoring of disease progression and treatment response. Microfluidic devices enable the integration of multiple sample preparation steps into a single platform, which speeds up processing and improves sensitivity. Such advancements in diagnostic technologies hold immense promise for revolutionizing the field of CRC diagnosis and enabling efficient detection and monitoring strategies. This article elucidates several of the latest developments in microfluidic technology for CRC diagnostics. In addition to the advancements in microfluidic technology for CRC diagnostics, the integration of artificial intelligence (AI) holds great promise for further enhancing diagnostic capabilities. Advancements in microfluidic systems and AI-driven approaches can revolutionize colorectal cancer diagnostics, offering accurate, efficient, and personalized strategies to improve patient outcomes and transform cancer management.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/bios13100926

Cites

113 of 113 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Schematic Illustration of Different Diagnostic Modalities for Colorectal Cancer.
Figure 1 Schematic Illustration of Different Diagnostic Modalities for Colorectal Cancer.CC BY · PubMed Central
Figure 2 Schematic Illustration of Different Strategies of Screening for Colorectal Cancer.
Figure 2 Schematic Illustration of Different Strategies of Screening for Colorectal Cancer.CC BY · PubMed Central
Figure 3 Illustration of Different Molecular Biomarker-based Detection for Colorectal Cancer.
Figure 3 Illustration of Different Molecular Biomarker-based Detection for Colorectal Cancer.CC BY · PubMed Central
Figure 4 Schematic Representation of Nano-Enhanced Imaging Techniques for Colorectal Cancer Diagnosis.
Figure 4 Schematic Representation of Nano-Enhanced Imaging Techniques for Colorectal Cancer Diagnosis.CC BY · PubMed Central
Figure 5 Schematic illustration (A1,A2) Integrated microfluidic device for CTC enrichment and analysis (B1,B2) Development of Integrated Microfluidic Device for Simultaneous Enrichment and Analysis of Circulating Tumor Cells, (C1) Comparative Immuno-staining Analysis of Captured Cells in PBS and Human Blood Samples [81]. (Reproduced with permission from Su, W.; Yu, H.; Jiang, L.; Chen, W.; Li, H.; Qin, J, Disease Markers; published by Hindawi, 2019).
Figure 5 Schematic illustration (A1,A2) Integrated microfluidic device for CTC enrichment and analysis (B1,B2) Development of Integrated Microfluidic Device for Simultaneous Enrichment and Analysis of Circulating Tumor Cells, (C1) Comparative Immuno-staining Analysis of Captured Cells in PBS and Human Blood Samples [81]. (Reproduced with permission from Su, W.; Yu, H.; Jiang, L.; Chen, W.; Li, H.; Qin, J, Disease Markers; published by Hindawi, 2019).CC BY · PubMed Central
Figure 6 Schematic representation illustrating the underlying mechanism of enzyme-aided fluorescence amplification based on GO-DNA aptamer interactions for exosome detection (Image taken from: Reproduced with permission from Wang, H.; Chen, H.; Huang, Z.; Li, T.; Deng, A.; Kong, J. Ta-lanta; published by Elsevier, 2018 [87].
Figure 6 Schematic representation illustrating the underlying mechanism of enzyme-aided fluorescence amplification based on GO-DNA aptamer interactions for exosome detection (Image taken from: Reproduced with permission from Wang, H.; Chen, H.; Huang, Z.; Li, T.; Deng, A.; Kong, J. Ta-lanta; published by Elsevier, 2018 [87].CC BY · PubMed Central
Figure 7 Schematic Illustration of Artificial Intelligence Model Building for Colorectal Cancer.
Figure 7 Schematic Illustration of Artificial Intelligence Model Building for Colorectal Cancer.CC BY · PubMed Central
Figure 8 Schematic Illustration of Unleashing the Potential of CRC Diagnostics: Pioneering Strategies for Diagnosis Interventions.
Figure 8 Schematic Illustration of Unleashing the Potential of CRC Diagnostics: Pioneering Strategies for Diagnosis Interventions.CC BY · PubMed Central
Figure 9 Schematic Representation of Next-Generation CRC Diagnosis.
Figure 9 Schematic Representation of Next-Generation CRC Diagnosis.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 113 references

Cited by

See all 60

Metadata

Authors
Beniwal, S., Lamo, P., Kaushik, A., Lorenzo-Villegas, D., Liu, Y., & MohanaSundaram, A.
Affiliations
  • Lady Hardinge Medical College (IN)
  • Universidad Internacional de La Rioja (ES)
  • Florida Polytechnic University (US)
  • Universidad Fernando Pessoa Canarias (ES)
  • Mayo Clinic (US)
  • Sathyabama Institute of Science and Technology (IN)
Corresponding author
  • Liu, Yuguang
  • MohanaSundaram, ArunSundar
Venue
Biosensors
Publisher
MDPI AG
Published
2023-10-13
Volume
13
Issue
10
Pages
926
ISSN
2079-6374 (ISSN-L)
OpenAlex
W4387642583
Cited by
60
References
112
Citations by year
2026: 17 · 2025: 24 · 2024: 19
FWCI
1.35
Type
journal article
Language
en
Open access
Locations
  • Biosensors (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Re-Unir (International University of La Rioja) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
  • Physical Sciences › Engineering › Biomedical Engineering › Biosensors and Analytical Detection
  • Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Bio-sensing Technologies
Keywords
colorectal cancer, cancer screening, cancer diagnosis, microfluidics, artificial intelligence, early detection, non-invasive diagnosis, treatment response monitoring
MeSH terms
Artificial Intelligence, Humans, Technology, Colorectal Neoplasms, Microfluidics, Early Detection of Cancer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Current Status and Emerging Trends in Colorectal Cancer Screening and Diagnostics. https://app.cochat.ai/papers/10.3390/bios13100926
The paper
Beniwal, S., Lamo, P., Kaushik, A., Lorenzo-Villegas, D., Liu, Y., & MohanaSundaram, A. (2023). Current Status and Emerging Trends in Colorectal Cancer Screening and Diagnostics. Biosensors. https://doi.org/10.3390/bios13100926

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.